Can Serum CA-125 Levels Predict the Optimal Primary Cytoreduction in Patients with Advanced Ovarian Carcinoma?
- 31 July 2002
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 86 (1) , 57-61
- https://doi.org/10.1006/gyno.2002.6719
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- What Are the Current Surgical Objectives, Strategies, and Technical Capabilities of Gynecologic Oncologists Treating Advanced Epithelial Ovarian Cancer?Gynecologic Oncology, 2001
- Preoperative Prediction of Optimal Resectability in Advanced Ovarian Cancer Using CA-125Gynecologic Oncology, 2000
- Spread of Ovarian Cancer after Laparoscopic Surgery: Report of Eight CasesGynecologic Oncology, 1999
- Preoperative Value of CA 125 as a Reflection of Tumor Grade in Epithelial Ovarian CancerGynecologic Oncology, 1996
- The Relationship between Postoperative Decline of Serum CA 125 Levels and Size of Residual Disease after Initial Surgery in Patients with Advanced Ovarian Cancer: A CTF StudyGynecologic Oncology, 1996
- Ovarian carcinoma: value of CT in predicting success of debulking surgery.American Journal of Roentgenology, 1995
- An Assessment of the Value of Serum CA 125 Measurements in the Management of Epithelial Ovarian CarcinomaGynecologic Oncology, 1994
- Tumor reduction surgery and long-term survival in advanced ovarian cancer: A DACOVA studyGynecologic Oncology, 1990
- AnnouncementGynecologic Oncology, 1986
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983